Cost of Off-label Antibiotics in Osteoarticular Infections

Status Terminated

Clinical Trial Summary

Due to the emergence of multidrug-resistant micro-organisms in patients with bone and joint infection (BJI), the prescription of off-labeled antibiotics seem to be more and more common as part of routine care. These new antibiotics are, however, more expensive, and there are no precise data in France regarding the volume and cost of such off-label prescriptions in hospital, in the post-acute care structures, and in the outpatient setting. The objective of this study is to estimate the cost of using these antibiotics over 2 years for patients in a reference center for the management of complex bone and joint infection (CRIOAc)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03335592
Study type	Observational
Source	Hospices Civils de Lyon
Contact
Status	Terminated
Phase
Start date	January 1, 2017
Completion date	April 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05519007` - Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone	N/A
Active, not recruiting	`NCT04563325` - Oral-only Antibiotics for Bone and Joint Infections in Children	Phase 4
Recruiting	`NCT05341908` - Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients
Recruiting	`NCT03550911` - Biological Collection From Samples From The Gut Microbiota In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine (CARBAMICROBIOTA)
Completed	`NCT04440631` - Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
Recruiting	`NCT05753215` - Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection	Phase 2
Recruiting	`NCT05137314` - Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)	Phase 1
Not yet recruiting	`NCT06293352` - Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection	N/A
Recruiting	`NCT04304885` - Effect of Sonication on Periprosthetic Joint Infection Treatment Strategy.
Completed	`NCT03403608` - Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint Infections	N/A
Recruiting	`NCT03704766` - Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis	N/A
Completed	`NCT00974493` - Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J)	Phase 4
Completed	`NCT03191292` - Bacterial Epidemiology and Empirical Antibiotherapy in Patients With Prosthetic Joint Infection	N/A
Recruiting	`NCT06191601` - Interest in Probabilistic Antibiotic Therapy With Broad-spectrum Beta-lactams in Orthopedic Surgery
Completed	`NCT05804058` - Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection
Enrolling by invitation	`NCT04723940` - Or v IV Antibiotics for Infection	Phase 3
Completed	`NCT03426761` - Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections	Phase 4
Enrolling by invitation	`NCT03713528` - Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?	Phase 4
Completed	`NCT04948281` - Joint Infection Following ACL Reconstruction
Completed	`NCT06267287` - Microbiological Structure of Pathogens of Periprosthetic Infection of Large Joints in the Post-Covid Period